Orthobiologics Market Outlook, Size, Share and Forecast 2023-2030

Orthobiologics Market Overview

Global Orthobiologics Market Poised for Steady Growth with a Projected CAGR of 5.40% from 2023 to 2030

In the ever-evolving landscape of healthcare, the Global Orthobiologics Market is anticipated to showcase robust growth, boasting a Compound Annual Growth Rate (CAGR) of 5.40% during the forecast period spanning 2023 to 2030.

Orthobiologics, utilized by orthopedic surgeons to expedite the healing process of injuries, play a pivotal role in facilitating the recovery of broken bones, injured muscles, tendons, and ligaments. These products, derived from naturally occurring substances within the human body, encompass platelet-rich plasma, bone marrow concentrate, specific fat grafts, and birth tissues. Whether autologous or allogeneic, these substances prove effective in promoting healing when injected or placed surgically in bones, joints, muscles, or tendons.

Market Summary: Key Metrics and Insights

CAGR: 5.40%

Segments Covered: By Product, By Application, By End User, and By Region

Report Highlights: Competitive Landscape Analysis, Company Profiles, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and other key insights.

Fastest Growing Region: Asia Pacific

Largest Market Share: North America

For a more in-depth understanding of the market trends, please refer to our Sample Brochure.

Market Dynamics: Driving Growth Through Awareness and Innovation

The surge in patient awareness regarding orthobiologics is anticipated to fuel market growth, with these products finding applications in reconstructive surgery, spinal fusion, and trauma recovery. The sports industry, in particular, has embraced orthobiologic treatments, addressing shattered bones and muscular injuries among athletes. Organizations like the American Medical Society for Sports Medicine (AMSSM) endorse the responsible use of regenerative medicine, including orthobiologics.

R&D investments and collaborations within the medical device and biotechnology sectors contribute to the development of advanced orthobiologics. Noteworthy is the collaboration between Bone Biologics Corp. and the University of California, currently in the development stages of the Nell-1 bone growth stimulator orthobiologic product.

However, the market faces challenges due to the fluctuating cost of orthobiologics, as highlighted in a study by the University of Alabama at Birmingham. Cost variability, ranging from a few hundred dollars to $12,000 in orthobiologics therapy, presents a hurdle to widespread adoption.

Market Segmentation Analysis: Synthetic Bone Substitutes Take Center Stage

The synthetic bone substitutes segment is projected to command the largest market share, driven by the increased incidence of bone and joint problems globally. Factors such as the rising global hip fracture rate and the prevalence of osteoporosis contribute to the demand for bone grafting procedures. Despite a temporary setback during the COVID-19 pandemic, the segment is expected to rebound with the gradual decline in infection rates and the resumption of production cycles.

Geographical Share: North America Leads the Way

North America leads the global orthobiologics market, attributed to factors such as a high prevalence of fractures, substantial R&D initiatives, and an increasing number of product launches. Miravo Healthcare's recent introduction of NeoVisc+ and NeoVisc ONE in Canada and Cerapedics' Health Canada-approved i-FACTOR+ Matrix are indicative of the region's dynamic market environment.

Key Players Shaping the Orthobiologics Market

Major players influencing the orthobiologics market include Medtronic Plc., Johnson & Johnson (DePuy Synthes), Sanofi, Integra LifeSciences Holdings Corporation, Arthrex, Inc., Zimmer Biomet, Stryker Corporation, Globus Medical Inc., Montagu (RTI Surgical), Seaspine Holdings Corporation, and Halma plc (NovaBone).

Related Reports:

Bone Cement Market

Chiropractic Care Market

Knee Braces Market

Fracture Fixation Products Market

Bone Wax Market

Tendinitis Treatment Market

About Us -

DataM Intelligence 4Market Research is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

Contact Us -

Name: Sai K

Designation: Sales & Senior Business Consultant

Email: info@datamintelligence.com

Phone: +1 877 441 4866

Website: https://www.datamintelligence.com